About this book:

"Genome-Guided Therapy: Precision Medicine in Diagnosis and Treatment Planning" offers a comprehensive exploration of how genomics is revolutionizing modern healthcare. This essential guide navigates the intricate journey from foundational genomic principles and biomarker discovery to the cutting-edge applications of Next-Generation Sequencing (NGS) and gene editing technologies. Across 25 detailed chapters, the book illuminates how personalized treatment strategies are being developed and implemented in diverse medical specialties, including oncology, cardiology, infectious diseases, and pediatrics. It showcases the power of molecular profiling to drive targeted therapies, optimize drug selection and dosing through pharmacogenomics, and accelerate diagnosis for rare diseases, moving decisively beyond one-size-fits-all approaches.

The book delves into the practical implementation of genome-guided therapy, covering critical areas such as interpreting genomic variants, the transformative impact of liquid biopsies for non-invasive surveillance, and the integration of multi-omics data for a holistic view of patient biology. It also thoroughly examines the indispensable role of artificial intelligence and machine learning in analyzing vast, complex genomic datasets, enhancing diagnostic accuracy, and personalizing treatment predictions. Crucially, "Genome-Guided Therapy" confronts the significant challenges of this evolving field, addressing regulatory pathways, health economics, reimbursement strategies, data management (security and privacy), and the profound ethical, legal, and societal implications that arise when harnessing the power to read and edit the human blueprint. Case studies highlight real-world successes and challenges, providing valuable lessons for clinicians and researchers.

Ultimately, this volume provides a forward-looking perspective on the innovations shaping the future of precision medicine. It emphasizes the need for widespread genomic literacy, robust clinical workflow integration, and a commitment to equitable access, ensuring that the transformative potential of genome-guided therapy translates into tangible improvements in patient care globally. Written for clinicians, healthcare professionals, and trainees, this book equips readers with the knowledge and context to confidently navigate the new era of personalized healthcare.

What You'll Find Inside:

• The shift from a 'one-size-fits-all' medical model to precision oncology, using molecular profiling to match patients with targeted therapies like TKIs and BRAF inhibitors.
• Fundamentals of human genomics, including the 'central dogma' of DNA-to-RNA-to-protein and the clinical significance of variants like SNPs, indels, and CNVs.
• Pharmacogenomics as a tool for optimizing drug selection and dosing, specifically regarding the CYP450 enzyme family and high-impact drug-gene pairs in psychiatry and cardiology.
• Technological advancements in Next-Generation Sequencing (NGS) and liquid biopsies for non-invasive genomic surveillance and minimal residual disease detection.
• Practical barriers to clinical implementation, including health economics, regulatory pathways, data security, and the necessity of 'genomic literacy' for healthcare providers.

Who's It For:

This book is primarily intended for clinicians, medical specialists, and healthcare trainees seeking to integrate genomic data into their diagnostic and treatment workflows. It is particularly beneficial for professionals in oncology, cardiology, psychiatry, and pediatrics who require a comprehensive understanding of biomarkers and targeted therapies. Additionally, healthcare administrators and policymakers will find value in the sections regarding health economics, reimbursement strategies, and the ethical implications of precision medicine.